Scholarlink

<p>Amelanotic melanoma involving the central nervous system (CNS) in association with congenital melanocytic naevi (CMN) is exceptionally rare and aggressive. Our literature review identified only two prior paediatric cases, reported in 1999 and 2021. To the best of our knowledge, this is the first reported paediatric case of CNS amelanotic melanoma with systemic metastases associated with CMN. We present a 2-year-old girl with CMN who developed an afebrile seizure, vomiting and neurological decline. Imaging revealed hydrocephalus, diffuse leptomeningeal enhancement, spinal cord compression and distant metastases. Histopathology confirmed metastatic amelanotic melanoma. She was treated with targeted therapy comprising trametinib and azacitidine, with a plan for immunotherapy (nivolumab and ipilimumab) after weaning off intravenous dexamethasone for cord compression. This case underscores the diagnostic challenge due to imaging similarities with other neoplastic, infectious and inflammatory pathologies. Given the aggressive nature and poor prognosis, a high index of suspicion should be raised for melanoma in patients with CMN and neurocutaneous melanosis who develop progressive neurological symptoms.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Amelanotic melanoma of the central nervous system with systemic spread – imaging pitfalls and clues in a rare paediatric case with congenital melanocytic naevi

  • 期刊论文

  • 发表日期：

    2025年11月28日

查看全文
  • Xin Yuan Tan,
  • Daniel Jing Wen Teh,
  • Timothy Shao Ern Tan

摘要

Amelanotic melanoma involving the central nervous system (CNS) in association with congenital melanocytic naevi (CMN) is exceptionally rare and aggressive. Our literature review identified only two prior paediatric cases, reported in 1999 and 2021. To the best of our knowledge, this is the first reported paediatric case of CNS amelanotic melanoma with systemic metastases associated with CMN. We present a 2-year-old girl with CMN who developed an afebrile seizure, vomiting and neurological decline. Imaging revealed hydrocephalus, diffuse leptomeningeal enhancement, spinal cord compression and distant metastases. Histopathology confirmed metastatic amelanotic melanoma. She was treated with targeted therapy comprising trametinib and azacitidine, with a plan for immunotherapy (nivolumab and ipilimumab) after weaning off intravenous dexamethasone for cord compression. This case underscores the diagnostic challenge due to imaging similarities with other neoplastic, infectious and inflammatory pathologies. Given the aggressive nature and poor prognosis, a high index of suspicion should be raised for melanoma in patients with CMN and neurocutaneous melanosis who develop progressive neurological symptoms.